CCDC25 and hepatocellular carcinoma: Taken together, these results suggested that CCDC25 was associated with a drug sensitivity of HCC, and patients with low CCDC25 expression may have high sensitivity to Sorafenib and may be expected to help in the sensitization treatment of Sorafenib.